Global Health Facts

At your fingertips

   Jun 13

Good Manufacturing Practice

China and India today have become just the superpowers in the production of such cheap raw materials, cheap and cheerful. The newspapers mentioned Gunnar Peterson not as a source, but as a related topic. Good manufacturing practice in all developed countries there are now laws that require to produce, store and distribute medications in accordance with certain rules. These rules are called "Good Manufacturing Practice or gmp. In principle, the eu, U.S., Japan and other developed countries, these rules are the same. The current Russian gmp standard is less demanding than its western counterpart, so that the probability violations and deviations in the Russian drugs produced slightly higher. The main problem – not the difference in the standard, it is not as important as high levels of corruption and not very tight control over the production of drugs in Russia, they have worse than in the West. Patents, the original drugs and generics develop a new drug is very expensive. It is no exaggeration to call the cost of doing so within a billion dollars.

Therefore, to encourage the development of the state around the world give us developer the exclusive right to manufacture and sell a new drug for, say, 5 years without any – or the competition. Upon completion of this period other firms can develop the technology and produce the drug. Compounding medicines to be identical, brand name will be different, but the international nonproprietary name remains the same. So there is no problems using clone-known drugs, provided that "cloning" was precise. This clone, a copy is called in professional language generics.

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.